Sanofi receives marketing approval for its diabetes drug Soliqua™ in India • Pre-filled pens containing a combination of insulin glargine 100 Units/mL and lixisenatide for once-daily dosing Mumbai, March 28, 2023 . Sanofi (India) announced t…
Read more